» Articles » PMID: 30807209

Mechanism-Based Modeling of Tumor Growth and Treatment Response Constrained by Multiparametric Imaging Data

Overview
Date 2019 Feb 27
PMID 30807209
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Multiparametric imaging is a critical tool in the noninvasive study and assessment of cancer. Imaging methods have evolved over the past several decades to provide quantitative measures of tumor and healthy tissue characteristics related to, for example, cell number, blood volume fraction, blood flow, hypoxia, and metabolism. Mechanistic models of tumor growth also have matured to a point where the incorporation of patient-specific measures could provide clinically relevant predictions of tumor growth and response. In this review, we identify and discuss approaches that use multiparametric imaging data, including diffusion-weighted magnetic resonance imaging, dynamic contrast-enhanced magnetic resonance imaging, diffusion tensor imaging, contrast-enhanced computed tomography, [F]fluorodeoxyglucose positron emission tomography, and [F]fluoromisonidazole positron emission tomography to initialize and calibrate mechanistic models of tumor growth and response. We focus the discussion on brain and breast cancers; however, we also identify three emerging areas of application in kidney, pancreatic, and lung cancers. We conclude with a discussion of the future directions for incorporating multiparametric imaging data and mechanistic modeling into clinical decision making for patients with cancer.

Citing Articles

Reconstruction of cancer marker analysis with holistic anatomical precision implicates heterogeneity development during breast tumor progression.

Ge Z, Wang J, He L, Zhao M, Si Y, Chang S Discov Oncol. 2024; 15(1):564.

PMID: 39406984 PMC: 11480302. DOI: 10.1007/s12672-024-01442-x.


Mechanistic modeling of cell viability assays with lineage tracing.

Mutsuddy A, Huggins J, Amrit A, Erdem C, Calhoun J, Birtwistle M bioRxiv. 2024; .

PMID: 39253474 PMC: 11383287. DOI: 10.1101/2024.08.23.609433.


Identifying Heterogeneous Micromechanical Properties of Biological Tissues via Physics-Informed Neural Networks.

Wu W, Daneker M, Turner K, Jolley M, Lu L Small Methods. 2024; 9(1):e2400620.

PMID: 39091065 PMC: 11747890. DOI: 10.1002/smtd.202400620.


From virtual patients to digital twins in immuno-oncology: lessons learned from mechanistic quantitative systems pharmacology modeling.

Wang H, Arulraj T, Ippolito A, Popel A NPJ Digit Med. 2024; 7(1):189.

PMID: 39014005 PMC: 11252162. DOI: 10.1038/s41746-024-01188-4.


Identifying heterogeneous micromechanical properties of biological tissues via physics-informed neural networks.

Wu W, Daneker M, Turner K, Jolley M, Lu L ArXiv. 2024; .

PMID: 38745694 PMC: 11092874.


References
1.
Lima E, Oden J, Wohlmuth B, Shahmoradi A, Hormuth 2nd D, Yankeelov T . Selection and Validation of Predictive Models of Radiation Effects on Tumor Growth Based on Noninvasive Imaging Data. Comput Methods Appl Mech Eng. 2017; 327:277-305. PMC: 5734134. DOI: 10.1016/j.cma.2017.08.009. View

2.
Koh D, Collins D . Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007; 188(6):1622-35. DOI: 10.2214/AJR.06.1403. View

3.
Bondiau P, Clatz O, Sermesant M, Marcy P, Delingette H, Frenay M . Biocomputing: numerical simulation of glioblastoma growth using diffusion tensor imaging. Phys Med Biol. 2008; 53(4):879-93. DOI: 10.1088/0031-9155/53/4/004. View

4.
Mosayebi P, Cobzas D, Murtha A, Jagersand M . Tumor invasion margin on the Riemannian space of brain fibers. Med Image Anal. 2011; 16(2):361-73. DOI: 10.1016/j.media.2011.10.001. View

5.
Chenevert T, Malyarenko D, Newitt D, Li X, Jayatilake M, Tudorica A . Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling. Transl Oncol. 2014; 7(1):65-71. PMC: 3998685. DOI: 10.1593/tlo.13811. View